Ralf Christian Bargou

14PUBLICATIONS
104CO-AUTHORS
Preventative health careMolecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 25, 2026
Author Correction: 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis.

Florencio Porto Freitas, Hamed Alborzinia, Ancély Ferreira Dos Santos

|Feb 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco

|Dec 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco

|Sep 11, 2024
Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma.

Marietheres Evers, Thorsten Stühmer, Martin Schreder

|May 31, 2024
Bispecific and multispecific antibodies in oncology: opportunities and challenges.

Maria-Elisabeth Goebeler, Gernot Stuhler, Ralf Bargou

|Jan 31, 2024
7-Dehydrocholesterol is an endogenous suppressor of ferroptosis.

Florencio Porto Freitas, Hamed Alborzinia, Ancély Ferreira Dos Santos

Pageof 3